Hugo Charles
Overview
Explore the profile of Hugo Charles including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
242
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uchiyama S, Hoshino T, Minematsu K, Meledje M, Charles H, Albers G, et al.
Eur Stroke J
. 2024 Nov;
:23969873241300071.
PMID: 39569585
Introduction: To investigate the clinical characteristics in patients without traditional risk factors (TRFs) after transient ischemic attack or minor ischemic stroke, who were recruited in the TIAregistry.org. Patients And Methods:...
2.
Lavallee P, Charles H, Labreuche J, Albers G, Caplan L, Donnan G, et al.
BMJ Open
. 2024 Jul;
14(7):e078632.
PMID: 38960468
Objectives: The objectives are to assess smoking abstinence and its effects on vascular risk and to report tobacco-cessation counselling and pharmacotherapy use in patients who had a recent minor stroke...
3.
Lavallee P, Charles H, Albers G, Caplan L, Donnan G, Ferro J, et al.
JAMA Neurol
. 2023 Oct;
80(11):1199-1208.
PMID: 37782494
Importance: The coexistence of underlying causes in patients with transient ischemic attack (TIA) or minor ischemic stroke as well as their associated 5-year risks are not well known. Objective: To...
4.
Amarenco P, Lavallee P, Kim J, Labreuche J, Charles H, Giroud M, et al.
Stroke
. 2023 Jun;
54(8):1993-2001.
PMID: 37376989
Background: Whether a strategy to target an LDL (low-density lipoprotein) cholesterol <70 mg/dL is more effective when LDL is reduced >50% from baseline rather than <50% from baseline has not...
5.
Lavallee P, Charles H, Albers G, Caplan L, Donnan G, Ferro J, et al.
Lancet Neurol
. 2023 Mar;
22(4):320-329.
PMID: 36931807
Background: The prevalence of atherosclerosis and the long-term risk of major vascular events in people who have had a transient ischaemic attack or minor ischaemic stroke, regardless of the causal...
6.
Amarenco P, Kim J, Labreuche J, Charles H, Giroud M, Lee B, et al.
Stroke
. 2022 Sep;
53(11):3260-3267.
PMID: 36154103
Background: In atherosclerotic stroke, lipid-lowering treatment with a target LDL (low-density lipoprotein) cholesterol of <70 compared with 100±10 mg/dL reduced the risk of subsequent cardiovascular events. This post hoc analysis...
7.
Hobeanu C, Lavallee P, Charles H, Labreuche J, Albers G, Caplan L, et al.
Lancet Neurol
. 2022 Sep;
21(10):889-898.
PMID: 36115361
Background: Patients who have had a transient ischaemic attack or minor stroke have an increased risk of cardiovascular events for the following 5 years. We aimed to assess 5-year functional...
8.
Amarenco P, Kim J, Labreuche J, Charles H, Giroud M, Lavallee P, et al.
Stroke
. 2021 Dec;
53(2):457-462.
PMID: 34963300
Background And Purpose: Although statins are effective in secondary prevention of ischemic stroke, they are also associated with an increase risk of intracranial hemorrhage (ICH) in certain conditions. In the...
9.
Amarenco P, Kim J, Labreuche J, Charles H, Giroud M, Lee B, et al.
Diabetes
. 2021 May;
70(8):1807-1815.
PMID: 33980690
After an ischemic stroke with evidence of atherosclerosis, lipid-lowering treatment with a target LDL cholesterol of <70 mg/dL compared with 100 ± 10 mg/dL reduced the risk of subsequent cardiovascular...
10.
Meseguer E, Diallo D, Labreuche J, Charles H, Delbosc S, Mangin G, et al.
J Clin Med
. 2020 Dec;
9(12).
PMID: 33322093
Establishing a prognosis at hospital admission after stroke is a major challenge. Inflammatory processes, hemostasis, vascular injury, and tissue remodeling are all involved in the early response to stroke. This...